227 related articles for article (PubMed ID: 31012565)
1. Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Extract Cream for Rejuvenation of the Face.
Alhaddad M; Boen M; Wu DC; Goldman MP
J Drugs Dermatol; 2019 Apr; 18(4):363-366. PubMed ID: 31012565
[TBL] [Abstract][Full Text] [Related]
2. Red Deer Umbilical Cord-Derived Stem Cell Conditioned Media Combined With Ablative Resurfacing of the Face.
Hoss E; Kollipara R; Alhaddad M; Boen M; Goldman MP
J Drugs Dermatol; 2020 Nov; 19(11):1044-1048. PubMed ID: 33196737
[TBL] [Abstract][Full Text] [Related]
3. The effect of human umbilical cord blood-derived mesenchymal stem cell media containing serum on recovery after laser treatment: A double-blinded, randomized, split-face controlled study.
Kim J; Kim B; Kim S; Lee YI; Kim J; Lee JH
J Cosmet Dermatol; 2020 Mar; 19(3):651-656. PubMed ID: 31328871
[TBL] [Abstract][Full Text] [Related]
4. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
5. A Prospective, Randomized, Double-blind, Split-face Clinical Trial Comparing the Efficacy of Two Topical Human Growth Factors for the Rejuvenation of the Aging Face.
Wu DC; Goldman MP
J Clin Aesthet Dermatol; 2017 May; 10(5):31-35. PubMed ID: 28670356
[No Abstract] [Full Text] [Related]
6. Improvement in Skin Elasticity Using Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Conditioned Media.
Ong C; Lim I; Goldman M; Hartman N; Masilamani J; Phan T
J Drugs Dermatol; 2023 Jan; 22(1):82-89. PubMed ID: 36607757
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
8. Single-Center, Double-Blind, Randomized, Placebo-Controlled, Study of the Efficacy and Safety of a Cream Formulation for Improving Facial Wrinkles and Skin Quality.
Sadick N; Bohnert K; Serra M; Kitchen N
J Drugs Dermatol; 2018 Jun; 17(6):664-669. PubMed ID: 29879254
[TBL] [Abstract][Full Text] [Related]
9. Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation.
Taub A; Bucay V; Keller G; Williams J; Mehregan D
J Drugs Dermatol; 2018 Apr; 17(4):426-441. PubMed ID: 29601620
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
[TBL] [Abstract][Full Text] [Related]
11. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
13. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS
Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521
[TBL] [Abstract][Full Text] [Related]
14. A Double-Blind, 12-Week Study to Evaluate the Antiaging Efficacy of a Cream Containing the NFκB Inhibitor 4-Hexyl-1, 3-Phenylenediol and Ascorbic Acid-2 Glucoside in Adult Females.
Roure R; Nollent V; Dayan L; Camel E; Bertin C
J Drugs Dermatol; 2016 Jun; 15(6):750-8. PubMed ID: 27272084
[TBL] [Abstract][Full Text] [Related]
15. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
[TBL] [Abstract][Full Text] [Related]
16. Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation.
Barone F; Bashey S; Woodin Jr. FW
J Drugs Dermatol; 2019 Mar; 18(3):290-295. PubMed ID: 30909351
[TBL] [Abstract][Full Text] [Related]
17. A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage.
Sanclemente G; Medina L; Villa JF; Barrera LM; Garcia HI
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):49-58. PubMed ID: 20456545
[TBL] [Abstract][Full Text] [Related]
18. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind, Comparative Clinical Study of Newly Formulated Retinol Serums vs Tretinoin Cream in Escalating Doses: A Method for Rapid Retinization With Minimized Irritation.
Draelos ZD; Peterson RS
J Drugs Dermatol; 2020 Jun; 19(6):625-631. PubMed ID: 32574009
[TBL] [Abstract][Full Text] [Related]
20. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies.
Nyirady J; Bergfeld W; Ellis C; Levine N; Savin R; Shavin J; Voorhees JJ; Weiss J; Grossman R
Cutis; 2001 Aug; 68(2):135-42. PubMed ID: 11534915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
